Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Chemours

Despite 3M’s phase-out, problem of cleaning up PFAS remains

3M announced in mid-December that it's phasing out a family of harmful chemicals, but they're not going away.

Tribune News Service

PFAS left dangerous blood compounds in nearly all US study participants

PFAS left dangerous blood compounds in nearly all US study participants

The toxic ‘forever chemicals’ can stay in human blood for years, and are linked to cancers, kidney damage and heart disease

The Guardian - US

High levels of ‘forever chemicals’ likely making alligators sick in Cape Fear River

High levels of ‘forever chemicals’ likely making alligators sick in Cape Fear River

Cape Fear River alligators’ blood showed much higher PFAS levels, and had twice as many compounds, as those in neighboring river

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022

Cancer fears plague residents of US region polluted by ‘forever chemicals’

Exposure to harmful PFAS remains almost impossible to escape – particularly for the people of the Cape Fear River basin

The Guardian - US

‘Forever chemical’ response may push costs to water utilities

WASHINGTON — Federal efforts to address pollution by so-called forever chemicals may push increased costs onto water and wastewater agencies.

Tribune News Service

'Forever chemical' response may push costs to water utilities - Roll Call

Federal efforts to address pollution by so-called forever chemicals may push increased costs onto water and wastewater agencies.

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

Analyst Ratings for Chemours

Analyst Ratings for Chemours

Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter:

Expert Ratings for Chemours

Expert Ratings for Chemours

Within the last quarter, Chemours (NYSE:CC) has observed the following analyst ratings:

Chemours: Q1 Earnings Insights

Chemours: Q1 Earnings Insights

Chemours (NYSE:CC) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by 58.7%, reporting an EPS of $1.46 versus an estimate of $0.92.

Scientists sound alarm at US regulator’s new ‘forever chemicals’ definition

Scientists sound alarm at US regulator’s new ‘forever chemicals’ definition

Narrower definition excludes chemicals in pharmaceuticals and pesticides that are generally defined as PFAS

The Guardian - US

Chemours: Q4 Earnings Insights

Chemours: Q4 Earnings Insights

Chemours (NYSE:CC) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours missed estimated earnings by 11.96%, reporting an EPS of $0.81 versus an estimate of $0.92.

Teflon’s River of Fear

Teflon’s River of Fear

Chemical giant Chemours is facing off against residents of North Carolina in a battle over a potentially harmful compound used to make nonstick pans.

Get all your
news in one place.

100’s of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

B of A Securities

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

254,425 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play